magnesium carbonate has been researched along with calcium acetate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Alfa, AK; Brewster, UC; Ciampi, MA; Reilly, RF | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Benedyk-Lorens, E; Covic, AC; de Francisco, AL; Ketteler, M; Leidig, M; Mircescu, GM; Passlick-Deetjen, J; Ponce, P; Scholz, C | 1 |
| Behets, GJ; D'Haese, PC; De Schutter, TM; Geryl, H; Gundlach, K; Neven, E; Passlick-Deetjen, J; Peter, ME; Steppan, S | 1 |
| Büschges-Seraphin, B; Covic, A; de Francisco, AL; Ghenu, A; Kroczak, M; Marzell, B; Passlick-Deetjen, J; Ponce, P | 1 |
| Abad, S; Arroyo, D; López-Gómez, JM; Panizo, N; Pérez-de José, A; Vega, A | 1 |
| Behets, GJ; Büchel, J; D'Haese, PC; Dams, G; De Schutter, TM; Gundlach, K; Neven, E; Passlick-Deetjen, J; Steppan, S | 1 |
| Albines, Z; Arias, M; Belmar, L; de Francisco, AL; Kislikova, M; Piñera, C; Sango, C; Seras, M; Serrano, M | 1 |
| Aires, I; Amaral, T; Azevedo, A; Ferreira, A; Ferreira, C; Gil, C; Jorge, C; Laranjinha, I; Matias, PJ; Mendes, M; Navarro, D; Stuard, S | 1 |
| Neradova, A; Schumacher, SP; Schurgers, LJ; Vervloet, MG | 1 |
1 review(s) available for magnesium carbonate and calcium acetate
| Article | Year |
|---|---|
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
2 trial(s) available for magnesium carbonate and calcium acetate
| Article | Year |
|---|---|
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium Compounds; Female; Humans; Hyperphosphatemia; Magnesium; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2010 |
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone and Bones; Calcium Compounds; Chelating Agents; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Kidney Function Tests; Magnesium; Male; Middle Aged; Parathyroid Hormone; Polyamines; Prognosis; Renal Dialysis; Risk Factors; Sevelamer; Young Adult | 2013 |
7 other study(ies) available for magnesium carbonate and calcium acetate
| Article | Year |
|---|---|
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Topics: Acetates; Bicarbonates; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Humans; Hypophosphatemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer | 2006 |
Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
Topics: Acetates; Adenine; Animals; Aortic Diseases; Bone Morphogenetic Protein 2; Calcium; Calcium Compounds; Calcium-Binding Proteins; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Gene Expression Regulation; Hyperphosphatemia; Kidney Failure, Chronic; Magnesium; Male; Matrix Gla Protein; Parathyroid Hormone; Phosphates; Polyamines; Rats; Rats, Wistar; Sevelamer; SOX9 Transcription Factor; Time Factors; Uremia; Vascular Calcification | 2013 |
The effect of replacing aluminium hydroxide with calcium acetate/magnesium carbonate on serum phosphorus control in haemodialysis patients.
Topics: Acetates; Aluminum Hydroxide; Calcium Compounds; Drug Substitution; Female; Humans; Magnesium; Male; Middle Aged; Phosphorus; Renal Dialysis | 2014 |
A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats.
Topics: Acetates; Animals; Biomarkers; Bone and Bones; Bone Remodeling; Calcium Compounds; Diet; Disease Models, Animal; Kidney Failure, Chronic; Magnesium; Male; Phosphates; Phosphorus; Rats; Vascular Calcification | 2014 |
Effect of calcium acetate/magnesium carbonate in the treatment of hyperphosphataemia in dialysis patients in real clinical practice. One year follow up.
Topics: Acetates; Calcium Compounds; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Magnesium; Male; Middle Aged; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome | 2014 |
Calcium Acetate/Magnesium Carbonate and Cardiovascular Risk Factors in Chronic Hemodialysis Patients.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Compounds; Cardiovascular Diseases; Humans; Magnesium; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors | 2016 |
Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Drug Combinations; Ferric Compounds; Hydrogen-Ion Concentration; Kinetics; Lanthanum; Magnesium; Phosphates; Sevelamer; Sucrose | 2019 |